𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy

✍ Scribed by K. NOMURA; K. KAWASUGI; T. MORIMOTO

Book ID
108710310
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
68 KB
Volume
15
Category
Article
ISSN
0961-5423

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cost-effectiveness of systemic and regio
Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases
✍ Isabelle Durand-Zaleski; Sally Earlam; Carol Fordy; Michael Davies; Timothy G. A πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 3 views

## Background: Management of unresectable colorectal liver metastases (clm) can be by regional (hepatic arterial infusion [hai]) or systemic chemotherapy, or by symptom control alone. in this study the costs of each type of management were related to clinical outcome in 134 patients with clm. ## M

A cost-effectiveness analysis of treatme
A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis
✍ Hyon K. Choi; John D. Seeger; Karen M. Kuntz πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Objective: Recently, new treatment options for rheumatoid arthritis (ra) patients with an inadequate response to methotrexate (mtx) have become available. given the wide variability in efficacy and costs among these different treatment options, we sought to determine their cost-effectiveness (ce

Cost-effectiveness analysis of day care
Cost-effectiveness analysis of day care for patients with dementia disorders
✍ Dr. Anders Wimo; Bengt Mattsson; Ingvar Krakau; Tua Eriksson; Anders Nelvig πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 832 KB

## Abstract In a cost‐effectiveness analysis, the costs of 55 demented patients in day care (DC) and 45 patients on a waiting list were related to the effects on indices measuring quality of life. Based on one year's study, the costs per patient per day, was USD 55 for the DC‐group and USD 63 for t